These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25920759)

  • 1. Efficacy of a combined inactivated porcine reproductive and respiratory syndrome virus vaccine using North American and European strains in specific pathogen free pigs.
    Yeom M; Lyoo KS; Kang BK; Song D; Park B
    Vet J; 2015 May; 204(2):157-61. PubMed ID: 25920759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
    Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
    Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
    Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
    Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
    Park C; Seo HW; Han K; Kang I; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination with porcine reproductive and respiratory syndrome virus following challenges with field isolates in Japan.
    Okuda Y; Kuroda M; Ono M; Chikata S; Shibata I
    J Vet Med Sci; 2008 Oct; 70(10):1017-25. PubMed ID: 18981655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena.
    Trus I; Bonckaert C; van der Meulen K; Nauwynck HJ
    Vaccine; 2014 May; 32(25):2995-3003. PubMed ID: 24709589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
    Jeong J; Choi K; Kang I; Park C; Chae C
    Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome.
    Mengeling WL; Lager KM; Vorwald AC; Clouser DF
    Vet Microbiol; 2003 May; 93(1):25-38. PubMed ID: 12591204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.
    Kim H; Kim HK; Jung JH; Choi YJ; Kim J; Um CG; Hyun SB; Shin S; Lee B; Jang G; Kang BK; Moon HJ; Song DS
    Virol J; 2011 Jun; 8():323. PubMed ID: 21703032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.